Pacific Biosciences Of California (PACB) Goodwill & Intangibles (2021 - 2026)
Pacific Biosciences Of California (PACB) recorded quarterly Goodwill & Intangibles of $331.9 million in Q1 2026, little changed quarter-over-quarter from $332.9 million in Q4 2025, and down 1.21% on a YoY basis from $335.9 million in Q1 2025.
Pacific Biosciences Of California (PACB) Goodwill & Intangibles (2021 - 2026) Analysis & Trends
Pacific Biosciences Of California's Goodwill & Intangibles history runs 6 years deep, the most recent figure standing at $331.9 million for Q1 2026.
- In Q1 2026, Goodwill & Intangibles fell 1.21% year-over-year to $331.9 million; the TTM figure through Mar 2026 stood at $331.9 million (down 1.21% YoY), while the FY2025 annual figure was $332.9 million, down 52.94% from the prior year.
- Goodwill & Intangibles was $331.9 million for Q1 2026 at Pacific Biosciences Of California, roughly flat from $332.9 million in the prior quarter.
- In the past five years, Goodwill & Intangibles ranged from a high of $925.6 million in Q3 2023 to a low of $331.9 million in Q1 2026.
- Historically, Goodwill & Intangibles has averaged $662.6 million across 5 years, with a median of $812.3 million in 2024.
- The sharpest annual moves came in 2024 and 2025: Goodwill & Intangibles jumped 38.89% in 2024, then plunged 63.18% in 2025.
- A 5-year view of Goodwill & Intangibles shows it stood at $820.2 million in 2022, then sank by 37.91% to $509.3 million in 2023, then surged by 38.89% to $707.3 million in 2024, then tumbled by 52.94% to $332.9 million in 2025, then fell by 0.31% to $331.9 million in 2026.
- The last three Goodwill & Intangibles figures came in at $331.9 million (Q1 2026), $332.9 million (Q4 2025), and $333.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Pacific Biosciences Of California | 426.62 Mn | 150.66 Mn | 12.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 331.87 Mn |
| Dec 31, 2025 | 332.89 Mn |
| Sep 30, 2025 | 333.90 Mn |
| Jun 30, 2025 | 334.92 Mn |
| Mar 31, 2025 | 335.94 Mn |
| Dec 31, 2024 | 707.33 Mn |
| Sep 30, 2024 | 805.49 Mn |
| Jun 30, 2024 | 812.34 Mn |
| Mar 31, 2024 | 912.39 Mn |
| Dec 31, 2023 | 509.27 Mn |
| Sep 30, 2023 | 925.64 Mn |
| Jun 30, 2023 | 819.75 Mn |
| Mar 31, 2023 | 819.99 Mn |
| Dec 31, 2022 | 820.22 Mn |
| Sep 30, 2022 | 820.27 Mn |
| Jun 30, 2022 | 820.50 Mn |
| Mar 31, 2022 | 820.73 Mn |
| Dec 31, 2021 | 820.95 Mn |
| Sep 20, 2021 | 790.67 Mn |